Reveal immune signatures in higher dimension.
Immune cell responses to cancer, infection or self are dynamic and complex. Translational studies, where cell and tumor samples are often limited in size and availability, pose a particular challenge when studying the complexity of immune response. Using higher-dimensional analyses, researchers are describing novel immune cell subsets with previously unrecognized functionalities at an ever-increasing rate.
At Fluidigm, we’re committed to providing you with the tools you need to explore immune responses from every angle—revealing new insights and identifying novel immune signatures in both health and disease.
Comprehensive end-to-end workflows from Fluidigm allow you to interrogate complex immune cell populations from every angle.
Visit us at Booth 519 to learn more.
Exhibit Dates & Hours
May 13–15, 2017
9:30 am–4:30 pm
Helios™, a CyTOF® System
Identify known and novel immune cell signatures using a wide range of cell surface and intracellular proteomic biomarkers.
Reveal gene expression signatures of tumor immune response using the Biomark HD.
Reveal the diversity of immune cell subpopulations and T cell receptor clonotypes in health and disease states at single cell resolution.